Should I buy Synaptics (SYNA) stock or is it too late?
No reliable analyst is bullish on this stock right now. A “reliable” analyst is a firm that, on this sector, hits more than 55% of its targets and beats its sector. None of them sees upside here — which is exactly why this stock is in no JPI selection.
Firm-by-firm track record on Synaptics
| Firm | % right | Gain vs sector | Calls | Aims for |
|---|---|---|---|---|
| Rosenblatt | 48 % | +14.1 % | 23 | $123 +3% |
| Craig-Hallum | 60 % | +11.6 % | 5 | $80 -33% |
| Needham | 46 % | +7.4 % | 28 | $105 -12% |
| Susquehanna | 33 % | -7.1 % | 9 | $125 +5% |
| JP Morgan | 56 % | -8.3 % | 18 | $115 -4% |
| Keybanc | 29 % | -8.4 % | 24 | $100 -16% |
| Mizuho | 28 % | -15.9 % | 18 | $170 +42% |
| Sterne Agee | 100 % | +57.0 % | 5 | — |
✅ Reasons to believe
- Few solid positives from analysts right now: of 8 ratings, only 2 buys, and the median price target ($125) is barely above the price (+5%, at $119). Caution prevails.
⚠️ Reasons to hesitate
- Even the most reliable firm on SYNA, JP Morgan (56% hit rate, 18 scored calls), only targets $115 (call made on May 8, 2026, maturing on May 8, 2027) (-4%) in its most recent call, and $100 (call made on February 6, 2026, maturing on February 6, 2027) (-16%) in the one coming due soonest. The stock may already have run past its target.
- The consensus is not unanimous: of 8 ratings, 6 are neutral.
- Limited upside: the median target is only +5% from the current price.
- A 12-month target is not a guaranteed path: the price can fall in the meantime.
- Volatile stock: sharp swings — including steep drops — are part of its profile.
- No dividend: your return depends only on price appreciation.
The analyst consensus on SYNA
Median target $125 (+5%) · 8 ratings · Hold consensus
⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.
Frequently asked questions
Should you invest in Synaptics now?
We won't decide for you. The facts: 25% of analysts rate it a buy, median target $125 (+5%), and JP Morgan (most reliable on SYNA, 56%) targets $115. Weigh that against valuation and volatility. This is not personalized advice.
Is it too late to invest in Synaptics?
Not according to analysts: the median target ($125) is still +5% above the current price ($119) (most reliable on SYNA: JP Morgan, 56%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.
Is Synaptics still worth investing in?
It depends on the gap between the price ($119) and its estimated value: analysts target $125 on median (+5%), with 25% buys (most reliable on SYNA: JP Morgan, 56%). Cross-check with their real reliability on SYNA and the cautions above. Information, not advice.
What's the main risk in buying SYNA?
Even the most reliable firm on SYNA, JP Morgan (56% hit rate, 18 scored calls), only targets $115 (call made on May 8, 2026, maturing on May 8, 2027) (-4%) in its most recent call, and $100 (call made on February 6, 2026, maturing on February 6, 2027) (-16%) in the one coming due soonest. The stock may already have run past its target.
→ Go deeper: the full Synaptics profile (consensus, analyst reliability, price target, performance).